Journal Highlight : Organ-on-a-Chip
The journal welcomes scholarly contributions related to microengineered biomimetic systems that replicate the structure, function, and physiological responses of human organs and tissues. This section focuses on research that advances organ-on-a-chip technologies for disease modeling, drug discovery, toxicology assessment, personalized medicine, and translational biomedical research.
The journal encourages submissions in areas including Microphysiological Systems, Lab-on-a-Chip Technologies, Biomimetic Tissue Models, Microfluidic Platforms, 3D Cell Culture Systems, Human-on-a-Chip Models, Tissue Engineering, Stem Cell–Based Organ Models, and Organotypic Disease Modeling. Research related to Lung-, Liver-, Heart-, Brain-, Kidney-, and Gut-on-a-Chip Systems, Cancer-on-a-Chip Technologies, Multi-Organ Interaction Models, Bioengineered Microenvironments, and Physiological Barrier Models is also welcomed.
Submissions focusing on Drug Screening and Toxicity Testing, Precision and Personalized Medicine Applications, AI and Computational Modeling in Organ-on-a-Chip Research, Pharmacokinetics and Pharmacodynamics Using Chip Platforms, Disease Mechanism Studies, Nanotechnology Integration, Translational Biomedical Engineering, and Regulatory and Industrial Applications of Organ-on-a-Chip Systems are encouraged. The journal also welcomes studies investigating physiological simulation, biomaterial interactions, real-time biosensing, and advanced chip-based technologies that improve preclinical and therapeutic research.
Accepted manuscript types include Original Research Articles, Systematic Reviews, Meta-Analyses, Experimental and Engineering Studies, Technology and Methodology Articles, Translational Biomedical Research Articles, and Interdisciplinary Pharmaceutical and Biomedical Studies that contribute to advancements in organ-on-a-chip technologies.
Through this focus area, the journal aims to support research that advances biomimetic and microphysiological systems, strengthens translational drug discovery and precision medicine, reduces reliance on conventional experimental models, and contributes to innovation in modern pharmaceutical, biomedical, and healthcare sciences worldwide.
